The CAR-TCR Summit is the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world.
Now four years established, the CAR-TCR Boston Summit continues to aspire to help the field realize the scientific potential and cure all cancer patients with breakthrough CAR-T & TCR cell therapies. Through industry defining, passionate and comprehensive content, the CAR-TCR Summit is dedicated to achieving two main goals:
With two CD19 approved drugs and the space getting increasingly crowded, this year’s CAR-TCR Summit will leverage the experience from those leaders first to market, whilst unveiling the next generation technologies and breakthroughs being developed to enhance CAR-TCR efficacy in solid tumor indications.
Become part of a dedicated community striving to deliver “curative” CAR-T & TCR cell therapies to patients in need.
"I can't speak highly enough about this conference. This conference allowed me to keep informed of the latest research and development on T cell therapies. I was also able to network with some of the leaders in T cell immunotherapies from both academia and the industry."
-Arnab Ghosh, Hematology & Medical Oncology Fellow, MSKCC, CAR-TCR Summit 2017 attendee